Muc1/Cd227 immunohistochemistry in routine practice is a useful biomarker in breast cancers.

Date publication

janvier 2013

Auteurs

Membres identifiés du Cancéropôle Est :
Dr GARBAR Christian , Pr BENSUSSAN Armand

Tous les auteurs :
Garbar C, Mascaux C, Cure H, Bensussan A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/23656244

Résumé

Over-expression of MUC1/CD227 is observed in 90% of breast tumors. Classical morphologic description and semi-quantitative digital measurement of MUC1 were performed from immunohistochemical stained slides of 123 routine histological samples. Measures of MUC1 expression showed statistical differences between non tumoral (NT) breast tissue and Ductal Carcinoma In Situ (DCIS) or infiltrating carcinoma (IC), p < 0.0001. Loss of MUC1 was correlated with high Ki67 index (p = 0.001) and loss of hormonal receptors (p = 0.03), whereas no correlations were found with HER2 expression. High-grade DCIS or IC showed increasing loss of apical polarised and cytoplasmic expression of MUC1.

Référence

J Immunoassay Immunochem. 2013;34(3):232-45